Companies / Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc.

Nasdaq: NVCTCIK 1875558FORT LEE, NJ

Financials

Revenue—
Net income$-26.44M
Total debt—
Cash$22.16M
Diluted EPS$-1.32
Shares outstanding32.6M

Ownership

32.6M shares outstanding · as of Jul 31, 2026
22.9%Insiders
Ownership
Insiders22.94%7,475,429
Institutions14.11%4,598,842
Public float62.94%20,507,262

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Bentsur RonCEOChairman & CEO · Director · 10% owner
11.28%3,675,924
Poradosu EnriqueChief Science & Business Off
5.54%1,806,319
Shemesh ShayChief Dev. & Ops. Officer
5.50%1,793,068
Carson Michael J.Vice President, Finance
0.61%200,118

Institutional holders 49

View all →
HolderValue% of shares
BlackRock, Inc.$18.41M3.07%
Vanguard Group Inc$6.38M2.60%
Iridian Asset Management LLC/CT$5.04M2.00%
State Street Corporation$4.56M0.76%
Geode Capital Management, LLC$2.97M1.18%
Baldwin Wealth Partners LLC/MA$2.93M1.16%
Occam Crest Management LP$2.87M1.17%
Susquehanna International Group, LLP$1.01M0.41%
Northern Trust Corp$878.9K0.36%
Oppenheimer & Co Inc$555.4K0.23%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$4.02M+218K
+27.91%
1,001,285
3.07% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$1.72M+94K
+60.47%
248,198
0.76% of shares
low
Q1 2026
as of
Iridian Asset Management LLC/CT
13F manager
AddCommon Stock$505.8K+65K
+11.16%
651,757
2.00% of shares
low
Q1 2026
as of
Marshall Wace, LLP
13F manager
NewCommon Stock$225.9K+29K
29,223
0.09% of shares
low
Q2 2025
as of
Barclays PLC
13F manager
AddCommon Stock$164.5K+22K
+1899.48%
23,174
0.07% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$155.3K+20K
+5.52%
384,105
1.18% of shares
low
Q1 2026
as of
Baldwin Wealth Partners LLC/MA
13F manager
TrimCommon Stock$-85.0K-11K
-2.82%
378,625
1.16% of shares
low
Q2 2026
as of
Deutsche Bank AG
13F manager
AddCommon Stock$77.3K+4K
+33.16%
16,874
0.05% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NVCTCommon StockEquity67080T108BBG012BCR149